MEI Pharma, Inc.
COMBINATION THERAPY

Last updated:

Abstract:

Provided herein are methods of treating diseases, such as cancer, using a combination therapy. In certain embodiments, the methods comprise administering an effective amount of a phosphoinositide-3-kinase (PI3K) inhibitor and an effective amount of a CD20 inhibitor to a patient.

Status:
Application
Type:

Utility

Filling date:

14 Aug 2018

Issue date:

16 Jul 2020